| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cAMP response element binding | 9.11e-09 | 12 | 43 | 4 | GO:0035497 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ATF7 ASCL4 NR4A3 RHOXF1 ATF3 NR4A1 SKI ZBTB7B ATF2 HELT CREB5 FOSB FOSL2 BACH1 FOSL1 TBX6 | 1.53e-08 | 1412 | 43 | 16 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ATF7 ASCL4 NR4A3 RHOXF1 ATF3 NR4A1 SKI ZBTB7B ATF2 HELT CREB5 FOSB FOSL2 BACH1 FOSL1 TBX6 | 2.43e-08 | 1459 | 43 | 16 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ATF7 NR4A3 ATF3 NR4A1 SKI ZBTB7B ATF2 HELT CREB5 FOSB FOSL2 BACH1 FOSL1 TBX6 | 1.75e-07 | 1244 | 43 | 14 | GO:0000978 |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 1.85e-07 | 6 | 43 | 3 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 1.85e-07 | 6 | 43 | 3 | GO:0055131 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ATF7 NR4A3 ATF3 NR4A1 SKI ZBTB7B ATF2 HELT CREB5 FOSB FOSL2 BACH1 FOSL1 TBX6 | 2.28e-07 | 1271 | 43 | 14 | GO:0000987 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 2.31e-07 | 560 | 43 | 10 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 2.55e-07 | 566 | 43 | 10 | GO:0001216 | |
| GeneOntologyMolecularFunction | transcription factor binding | 3.40e-06 | 753 | 43 | 10 | GO:0008134 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 4.16e-06 | 15 | 43 | 3 | GO:0140776 | |
| GeneOntologyMolecularFunction | denatured protein binding | 1.36e-05 | 3 | 43 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.77e-05 | 417 | 43 | 7 | GO:0061629 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 2.93e-05 | 582 | 43 | 8 | GO:0140297 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 4.51e-05 | 5 | 43 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 6.63e-05 | 326 | 43 | 6 | GO:0001217 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor binding | 7.96e-05 | 337 | 43 | 6 | GO:0001664 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 8.41e-05 | 875 | 43 | 9 | GO:0019904 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 8.69e-05 | 40 | 43 | 3 | GO:0140662 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 2.78e-04 | 147 | 43 | 4 | GO:0042826 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 3.07e-04 | 61 | 43 | 3 | GO:0098531 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 5.21e-04 | 73 | 43 | 3 | GO:0044183 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 5.99e-04 | 320 | 43 | 5 | GO:0001227 | |
| GeneOntologyMolecularFunction | misfolded protein binding | 6.78e-04 | 18 | 43 | 2 | GO:0051787 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 7.56e-04 | 337 | 43 | 5 | GO:0031625 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 8.40e-04 | 20 | 43 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | death receptor activity | 9.27e-04 | 21 | 43 | 2 | GO:0005035 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 9.91e-04 | 358 | 43 | 5 | GO:0044389 | |
| GeneOntologyMolecularFunction | adrenergic receptor binding | 1.21e-03 | 24 | 43 | 2 | GO:0031690 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 1.23e-03 | 775 | 43 | 7 | GO:0017111 | |
| GeneOntologyMolecularFunction | G-protein beta/gamma-subunit complex binding | 1.32e-03 | 25 | 43 | 2 | GO:0031683 | |
| GeneOntologyMolecularFunction | dopamine receptor binding | 1.42e-03 | 26 | 43 | 2 | GO:0050780 | |
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 1.65e-03 | 28 | 43 | 2 | GO:0005242 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.94e-03 | 839 | 43 | 7 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.95e-03 | 840 | 43 | 7 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.95e-03 | 840 | 43 | 7 | GO:0016818 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 2.52e-03 | 126 | 43 | 3 | GO:0051082 | |
| GeneOntologyMolecularFunction | NF-kappaB binding | 2.72e-03 | 36 | 43 | 2 | GO:0051059 | |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 2.72e-03 | 36 | 43 | 2 | GO:0140416 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 3.19e-03 | 39 | 43 | 2 | GO:0097718 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 3.76e-03 | 1205 | 43 | 8 | GO:0046983 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 4.27e-03 | 152 | 43 | 3 | GO:0022843 | |
| GeneOntologyMolecularFunction | chromatin binding | 4.78e-03 | 739 | 43 | 6 | GO:0003682 | |
| GeneOntologyMolecularFunction | ADP binding | 4.80e-03 | 48 | 43 | 2 | GO:0043531 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 5.19e-03 | 163 | 43 | 3 | GO:0031072 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 6.04e-03 | 54 | 43 | 2 | GO:0001223 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 6.91e-03 | 562 | 43 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 7.03e-03 | 182 | 43 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | G protein activity | 7.17e-03 | 59 | 43 | 2 | GO:0003925 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 7.25e-03 | 184 | 43 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 7.41e-03 | 60 | 43 | 2 | GO:0004879 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 7.58e-03 | 187 | 43 | 3 | GO:0016922 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 9.93e-03 | 614 | 43 | 5 | GO:0140657 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 1.04e-02 | 398 | 43 | 4 | GO:0046982 | |
| GeneOntologyMolecularFunction | protein kinase binding | 1.05e-02 | 873 | 43 | 6 | GO:0019901 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 1.23e-02 | 78 | 43 | 2 | GO:0003725 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.31e-02 | 229 | 43 | 3 | GO:0003714 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.38e-02 | 83 | 43 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | virus receptor activity | 1.44e-02 | 85 | 43 | 2 | GO:0001618 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.47e-02 | 441 | 43 | 4 | GO:0016887 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 1.48e-02 | 86 | 43 | 2 | GO:0140272 | |
| GeneOntologyMolecularFunction | kinase binding | 1.69e-02 | 969 | 43 | 6 | GO:0019900 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | KANSL3 ATF7 NR4A3 ATF3 CAMTA2 NR4A1 SKI ZBTB7B KDM4C ATF2 HELT CREB5 FOSB FOSL2 BACH1 FOSL1 TBX6 | 1.33e-09 | 1390 | 44 | 17 | GO:0045944 |
| GeneOntologyBiologicalProcess | response to steroid hormone | 1.25e-06 | 381 | 44 | 8 | GO:0048545 | |
| GeneOntologyBiologicalProcess | NK T cell differentiation | 3.24e-06 | 14 | 44 | 3 | GO:0001865 | |
| GeneOntologyBiologicalProcess | response to hormone | NR4A3 GNAS NR4A1 ZBTB7B HSPA1A HSPA1B KDM4C HSPA8 FOSB FOSL2 FOSL1 | 8.55e-06 | 1042 | 44 | 11 | GO:0009725 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 9.44e-06 | 1053 | 44 | 11 | GO:0000122 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 1.87e-05 | 727 | 44 | 9 | GO:0032870 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | ATF7 NR4A3 ATF3 SKI ZBTB7B HSPA1A ATF2 HELT HSPA8 FOSB BACH1 TBX6 | 2.49e-05 | 1399 | 44 | 12 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | ATF7 NR4A3 ATF3 SKI ZBTB7B HSPA1A ATF2 HELT HSPA8 FOSB BACH1 TBX6 | 2.75e-05 | 1413 | 44 | 12 | GO:1902679 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 3.06e-05 | 286 | 44 | 6 | GO:0007188 | |
| GeneOntologyBiologicalProcess | fat cell differentiation | 3.37e-05 | 291 | 44 | 6 | GO:0045444 | |
| GeneOntologyBiologicalProcess | protein refolding | 3.53e-05 | 30 | 44 | 3 | GO:0042026 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 5.61e-05 | 1048 | 44 | 10 | GO:0014070 | |
| GeneOntologyBiologicalProcess | chaperone cofactor-dependent protein refolding | 5.65e-05 | 35 | 44 | 3 | GO:0051085 | |
| GeneOntologyBiologicalProcess | cellular heat acclimation | 6.64e-05 | 6 | 44 | 2 | GO:0070370 | |
| GeneOntologyBiologicalProcess | cellular response to corticotropin-releasing hormone stimulus | 6.64e-05 | 6 | 44 | 2 | GO:0071376 | |
| GeneOntologyBiologicalProcess | response to corticotropin-releasing hormone | 6.64e-05 | 6 | 44 | 2 | GO:0043435 | |
| GeneOntologyBiologicalProcess | 'de novo' post-translational protein folding | 9.12e-05 | 41 | 44 | 3 | GO:0051084 | |
| GeneOntologyBiologicalProcess | heat acclimation | 9.28e-05 | 7 | 44 | 2 | GO:0010286 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 9.28e-05 | 7 | 44 | 2 | GO:0070434 | |
| GeneOntologyBiologicalProcess | response to lipid | 1.02e-04 | 1126 | 44 | 10 | GO:0033993 | |
| GeneOntologyBiologicalProcess | response to progesterone | 1.21e-04 | 45 | 44 | 3 | GO:0032570 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule nucleation | 1.24e-04 | 8 | 44 | 2 | GO:0090063 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 1.24e-04 | 8 | 44 | 2 | GO:0070426 | |
| GeneOntologyBiologicalProcess | 'de novo' protein folding | 1.29e-04 | 46 | 44 | 3 | GO:0006458 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 1.40e-04 | 124 | 44 | 4 | GO:0060349 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 1.50e-04 | 239 | 44 | 5 | GO:0071383 | |
| GeneOntologyBiologicalProcess | embryo development | 1.63e-04 | 1437 | 44 | 11 | GO:0009790 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane permeability | 1.66e-04 | 50 | 44 | 3 | GO:1905710 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 2.40e-04 | 416 | 44 | 6 | GO:0030522 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 2.42e-04 | 11 | 44 | 2 | GO:0070432 | |
| GeneOntologyBiologicalProcess | response to unfolded protein | 2.76e-04 | 148 | 44 | 4 | GO:0006986 | |
| GeneOntologyBiologicalProcess | negative regulation of inclusion body assembly | 2.90e-04 | 12 | 44 | 2 | GO:0090084 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor-mediated signaling pathway | 3.98e-04 | 14 | 44 | 2 | GO:1903265 | |
| GeneOntologyBiologicalProcess | regulation of cell development | 4.27e-04 | 1095 | 44 | 9 | GO:0060284 | |
| GeneOntologyBiologicalProcess | response to topologically incorrect protein | 4.27e-04 | 166 | 44 | 4 | GO:0035966 | |
| GeneOntologyBiologicalProcess | response to oxidative stress | 5.02e-04 | 478 | 44 | 6 | GO:0006979 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 5.24e-04 | 16 | 44 | 2 | GO:0070424 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 5.83e-04 | 906 | 44 | 8 | GO:0043009 | |
| GeneOntologyBiologicalProcess | adipose tissue development | 6.40e-04 | 79 | 44 | 3 | GO:0060612 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 6.40e-04 | 79 | 44 | 3 | GO:0060350 | |
| GeneOntologyBiologicalProcess | chaperone-mediated protein folding | 6.64e-04 | 80 | 44 | 3 | GO:0061077 | |
| GeneOntologyBiologicalProcess | response to corticosterone | 6.66e-04 | 18 | 44 | 2 | GO:0051412 | |
| GeneOntologyBiologicalProcess | vacuolar transport | 6.69e-04 | 187 | 44 | 4 | GO:0007034 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 6.87e-04 | 929 | 44 | 8 | GO:0009792 | |
| GeneOntologyBiologicalProcess | cellular response to heat | 6.88e-04 | 81 | 44 | 3 | GO:0034605 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 7.24e-04 | 191 | 44 | 4 | GO:0007189 | |
| GeneOntologyBiologicalProcess | regulation of membrane permeability | 7.39e-04 | 83 | 44 | 3 | GO:0090559 | |
| GeneOntologyBiologicalProcess | regulation of microtubule nucleation | 7.43e-04 | 19 | 44 | 2 | GO:0010968 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 8.21e-04 | 525 | 44 | 6 | GO:0009410 | |
| GeneOntologyBiologicalProcess | nucleotide-binding oligomerization domain containing 2 signaling pathway | 8.25e-04 | 20 | 44 | 2 | GO:0070431 | |
| GeneOntologyBiologicalProcess | regulation of type B pancreatic cell proliferation | 9.10e-04 | 21 | 44 | 2 | GO:0061469 | |
| GeneOntologyBiologicalProcess | regulation of inclusion body assembly | 9.10e-04 | 21 | 44 | 2 | GO:0090083 | |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | 1.06e-03 | 1242 | 44 | 9 | GO:0002684 | |
| GeneOntologyBiologicalProcess | immune response-activating signaling pathway | 1.07e-03 | 553 | 44 | 6 | GO:0002757 | |
| GeneOntologyBiologicalProcess | regulation of mitotic spindle assembly | 1.19e-03 | 24 | 44 | 2 | GO:1901673 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | 1.25e-03 | 1272 | 44 | 9 | GO:1901698 | |
| GeneOntologyBiologicalProcess | cellular response to unfolded protein | 1.27e-03 | 100 | 44 | 3 | GO:0034620 | |
| GeneOntologyBiologicalProcess | skeletal muscle tissue development | 1.29e-03 | 223 | 44 | 4 | GO:0007519 | |
| GeneOntologyBiologicalProcess | white fat cell differentiation | 1.29e-03 | 25 | 44 | 2 | GO:0050872 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating adrenergic receptor signaling pathway | 1.29e-03 | 25 | 44 | 2 | GO:0071880 | |
| GeneOntologyBiologicalProcess | hepatocyte apoptotic process | 1.62e-03 | 28 | 44 | 2 | GO:0097284 | |
| GeneOntologyBiologicalProcess | skeletal muscle organ development | 1.68e-03 | 240 | 44 | 4 | GO:0060538 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 1.70e-03 | 605 | 44 | 6 | GO:0071407 | |
| GeneOntologyBiologicalProcess | growth plate cartilage development | 1.74e-03 | 29 | 44 | 2 | GO:0003417 | |
| GeneOntologyBiologicalProcess | immune response-regulating signaling pathway | 1.85e-03 | 615 | 44 | 6 | GO:0002764 | |
| GeneOntologyBiologicalProcess | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 1.86e-03 | 30 | 44 | 2 | GO:0035872 | |
| GeneOntologyBiologicalProcess | female pregnancy | 1.93e-03 | 249 | 44 | 4 | GO:0007565 | |
| GeneOntologyBiologicalProcess | cellular response to topologically incorrect protein | 1.94e-03 | 116 | 44 | 3 | GO:0035967 | |
| GeneOntologyBiologicalProcess | activation of immune response | 1.97e-03 | 623 | 44 | 6 | GO:0002253 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | 2.00e-03 | 1361 | 44 | 9 | GO:0009628 | |
| GeneOntologyBiologicalProcess | response to ketone | 2.07e-03 | 254 | 44 | 4 | GO:1901654 | |
| GeneOntologyBiologicalProcess | organ growth | 2.13e-03 | 256 | 44 | 4 | GO:0035265 | |
| GeneOntologyBiologicalProcess | response to heat | 2.19e-03 | 121 | 44 | 3 | GO:0009408 | |
| GeneOntologyBiologicalProcess | inclusion body assembly | 2.25e-03 | 33 | 44 | 2 | GO:0070841 | |
| GeneOntologyBiologicalProcess | bone development | 2.38e-03 | 264 | 44 | 4 | GO:0060348 | |
| GeneOntologyBiologicalProcess | regulation of spindle assembly | 2.39e-03 | 34 | 44 | 2 | GO:0090169 | |
| GeneOntologyBiologicalProcess | regulation of body fluid levels | 2.41e-03 | 442 | 44 | 5 | GO:0050878 | |
| GeneOntologyBiologicalProcess | response to hydrogen peroxide | 2.46e-03 | 126 | 44 | 3 | GO:0042542 | |
| GeneOntologyBiologicalProcess | adrenergic receptor signaling pathway | 2.53e-03 | 35 | 44 | 2 | GO:0071875 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic pattern recognition receptor signaling pathway | 2.62e-03 | 129 | 44 | 3 | GO:0039531 | |
| GeneOntologyCellularComponent | chromatin | KANSL3 ATF7 ASCL4 NR4A3 RHOXF1 ATF3 TFPT CAMTA2 NR4A1 KDM4C ATF2 HELT CREB5 FOSB FOSL2 BACH1 FOSL1 TBX6 | 4.90e-10 | 1480 | 45 | 18 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | 3.89e-08 | 596 | 45 | 11 | GO:0005667 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.74e-06 | 272 | 45 | 7 | GO:0090575 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | ATF7 ASCL4 ATF3 TFPT CLP1 HSPA1A HSPA1B ATF2 HSPA8 FOSL2 BACH1 FOSL1 | 2.39e-05 | 1377 | 45 | 12 | GO:0140513 |
| GeneOntologyCellularComponent | cell body | 7.36e-04 | 929 | 45 | 8 | GO:0044297 | |
| GeneOntologyCellularComponent | neuronal cell body | 1.91e-03 | 835 | 45 | 7 | GO:0043025 | |
| GeneOntologyCellularComponent | focal adhesion | 2.26e-03 | 431 | 45 | 5 | GO:0005925 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule lumen | 2.41e-03 | 124 | 45 | 3 | GO:1904813 | |
| GeneOntologyCellularComponent | cell-substrate junction | 2.54e-03 | 443 | 45 | 5 | GO:0030055 | |
| GeneOntologyCellularComponent | heterotrimeric G-protein complex | 2.58e-03 | 35 | 45 | 2 | GO:0005834 | |
| GeneOntologyCellularComponent | COP9 signalosome | 3.03e-03 | 38 | 45 | 2 | GO:0008180 | |
| GeneOntologyCellularComponent | aggresome | 3.36e-03 | 40 | 45 | 2 | GO:0016235 | |
| GeneOntologyCellularComponent | GTPase complex | 3.52e-03 | 41 | 45 | 2 | GO:1905360 | |
| GeneOntologyCellularComponent | blood microparticle | 3.68e-03 | 144 | 45 | 3 | GO:0072562 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 4.23e-03 | 45 | 45 | 2 | GO:1902562 | |
| Domain | bZIP_1 | 1.23e-14 | 34 | 46 | 8 | PF00170 | |
| Domain | TF_DNA-bd | 2.61e-14 | 37 | 46 | 8 | IPR008917 | |
| Domain | BRLZ | 4.94e-13 | 52 | 46 | 8 | SM00338 | |
| Domain | BZIP | 5.81e-13 | 53 | 46 | 8 | PS50217 | |
| Domain | BZIP_BASIC | 5.81e-13 | 53 | 46 | 8 | PS00036 | |
| Domain | bZIP | 6.81e-13 | 54 | 46 | 8 | IPR004827 | |
| Domain | AP-1 | 4.02e-09 | 9 | 46 | 4 | IPR000837 | |
| Domain | TF_CRE-BP1-typ | 1.40e-08 | 3 | 46 | 3 | IPR016378 | |
| Domain | K_chnl_inward-rec_Kir2.2 | 5.93e-06 | 2 | 46 | 2 | IPR003272 | |
| Domain | HSP70 | 7.66e-06 | 16 | 46 | 3 | PF00012 | |
| Domain | bZIP_2 | 9.28e-06 | 17 | 46 | 3 | PF07716 | |
| Domain | HSP70_2 | 9.28e-06 | 17 | 46 | 3 | PS00329 | |
| Domain | HSP70_3 | 9.28e-06 | 17 | 46 | 3 | PS01036 | |
| Domain | HSP70_1 | 9.28e-06 | 17 | 46 | 3 | PS00297 | |
| Domain | Hsp_70_fam | 1.11e-05 | 18 | 46 | 3 | IPR013126 | |
| Domain | Nuc_orph_rcpt | 1.78e-05 | 3 | 46 | 2 | IPR003070 | |
| Domain | K_chnl_inward-rec_Kir_N | 1.78e-05 | 3 | 46 | 2 | IPR013673 | |
| Domain | IRK_N | 1.78e-05 | 3 | 46 | 2 | PF08466 | |
| Domain | - | 3.86e-04 | 12 | 46 | 2 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 3.86e-04 | 12 | 46 | 2 | IPR029047 | |
| Domain | - | 4.55e-04 | 13 | 46 | 2 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 4.55e-04 | 13 | 46 | 2 | IPR018181 | |
| Domain | HSP70_C | 4.55e-04 | 13 | 46 | 2 | IPR029048 | |
| Domain | G-alpha | 6.97e-04 | 16 | 46 | 2 | PF00503 | |
| Domain | GproteinA_insert | 6.97e-04 | 16 | 46 | 2 | IPR011025 | |
| Domain | K_chnl_inward-rec_Kir_cyto | 6.97e-04 | 16 | 46 | 2 | IPR013518 | |
| Domain | IRK | 6.97e-04 | 16 | 46 | 2 | PF01007 | |
| Domain | - | 6.97e-04 | 16 | 46 | 2 | 2.60.40.1400 | |
| Domain | K_chnl_inward-rec_Kir | 6.97e-04 | 16 | 46 | 2 | IPR016449 | |
| Domain | G_alpha | 6.97e-04 | 16 | 46 | 2 | SM00275 | |
| Domain | - | 6.97e-04 | 16 | 46 | 2 | 1.10.400.10 | |
| Domain | Gprotein_alpha_su | 7.88e-04 | 17 | 46 | 2 | IPR001019 | |
| Domain | Ig_E-set | 2.14e-03 | 104 | 46 | 3 | IPR014756 | |
| Domain | zf-C4 | 5.73e-03 | 46 | 46 | 2 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 5.73e-03 | 46 | 46 | 2 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 5.73e-03 | 46 | 46 | 2 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 5.73e-03 | 46 | 46 | 2 | IPR001723 | |
| Domain | ZnF_C4 | 5.73e-03 | 46 | 46 | 2 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 5.73e-03 | 46 | 46 | 2 | PS51030 | |
| Domain | - | 5.98e-03 | 47 | 46 | 2 | 1.10.565.10 | |
| Domain | HOLI | 6.23e-03 | 48 | 46 | 2 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 6.23e-03 | 48 | 46 | 2 | IPR000536 | |
| Domain | Hormone_recep | 6.23e-03 | 48 | 46 | 2 | PF00104 | |
| Domain | - | 8.69e-03 | 57 | 46 | 2 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 8.99e-03 | 58 | 46 | 2 | IPR013088 | |
| Domain | - | 9.56e-03 | 746 | 46 | 6 | 3.40.50.300 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 9.10e-07 | 29 | 37 | 4 | M47515 | |
| Pathway | PID_AP1_PATHWAY | 1.01e-06 | 70 | 37 | 5 | M167 | |
| Pathway | KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.20e-06 | 31 | 37 | 4 | M47507 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.37e-06 | 32 | 37 | 4 | M47506 | |
| Pathway | WP_MAPK_SIGNALING | 2.98e-06 | 246 | 37 | 7 | M39597 | |
| Pathway | WP_MAPK_SIGNALING_PATHWAY | 3.38e-06 | 160 | 37 | 6 | MM15990 | |
| Pathway | WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING | 3.92e-06 | 92 | 37 | 5 | M39441 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 4.68e-06 | 13 | 37 | 3 | MM14952 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 5.12e-06 | 267 | 37 | 7 | M10792 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY | 9.10e-06 | 16 | 37 | 3 | M47551 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKACA_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.10e-05 | 17 | 37 | 3 | M47514 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKAR1A_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.32e-05 | 18 | 37 | 3 | M47516 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PDE11A_PDE8B_TO_ACTH_CORTISOL_SIGNALING_PATHWAY | 1.84e-05 | 20 | 37 | 3 | M47517 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 2.84e-05 | 23 | 37 | 3 | MM14953 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 3.24e-05 | 24 | 37 | 3 | M47520 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 4.66e-05 | 27 | 37 | 3 | M47518 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 5.21e-05 | 28 | 37 | 3 | M27254 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY | 5.21e-05 | 28 | 37 | 3 | M47647 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY | 5.80e-05 | 29 | 37 | 3 | M47627 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 6.07e-05 | 82 | 37 | 4 | M2 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 1.32e-04 | 38 | 37 | 3 | M27255 | |
| Pathway | REACTOME_NGF_STIMULATED_TRANSCRIPTION | 1.43e-04 | 39 | 37 | 3 | M29793 | |
| Pathway | WP_OREXIN_RECEPTOR_PATHWAY | 1.65e-04 | 200 | 37 | 5 | M48048 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 3.00e-04 | 50 | 37 | 3 | M48087 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 3.37e-04 | 52 | 37 | 3 | MM14949 | |
| Pathway | REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA | 3.98e-04 | 55 | 37 | 3 | MM15137 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 4.42e-04 | 57 | 37 | 3 | M27251 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_CREB_MEDIATED_TRANSCRIPTION | 5.13e-04 | 13 | 37 | 2 | M47595 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_CREB_MEDIATED_TRANSCRIPTION | 5.13e-04 | 13 | 37 | 2 | M47674 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 5.39e-04 | 61 | 37 | 3 | M152 | |
| Pathway | BIOCARTA_RANKL_PATHWAY | 5.98e-04 | 14 | 37 | 2 | M2602 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 6.80e-04 | 66 | 37 | 3 | MM17074 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | 8.41e-04 | 71 | 37 | 3 | M39690 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 9.12e-04 | 73 | 37 | 3 | MM14948 | |
| Pathway | WP_APOPTOSIS_MODULATION_BY_HSP70 | 9.99e-04 | 18 | 37 | 2 | MM15964 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 1.03e-03 | 76 | 37 | 3 | M48037 | |
| Pathway | REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL | 1.11e-03 | 19 | 37 | 2 | MM15194 | |
| Pathway | WP_HYPERTROPHY_MODEL | 1.11e-03 | 19 | 37 | 2 | MM15938 | |
| Pathway | WP_HYPERTROPHY_MODEL | 1.24e-03 | 20 | 37 | 2 | M39674 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.28e-03 | 82 | 37 | 3 | M27250 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY | 1.36e-03 | 21 | 37 | 2 | M47792 | |
| Pathway | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | 1.47e-03 | 86 | 37 | 3 | MM15140 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 1.57e-03 | 88 | 37 | 3 | M16004 | |
| Pathway | KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY | 1.64e-03 | 23 | 37 | 2 | M47799 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.64e-03 | 23 | 37 | 2 | M47512 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 1.78e-03 | 92 | 37 | 3 | MM14951 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TNF_P38_SIGNALING_PATHWAY | 1.78e-03 | 24 | 37 | 2 | M47568 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.78e-03 | 24 | 37 | 2 | M47509 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 1.89e-03 | 94 | 37 | 3 | MM14515 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.94e-03 | 25 | 37 | 2 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.94e-03 | 25 | 37 | 2 | M47511 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY | 2.09e-03 | 26 | 37 | 2 | M47553 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY | 2.26e-03 | 27 | 37 | 2 | M47519 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.32e-03 | 101 | 37 | 3 | M27253 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.43e-03 | 28 | 37 | 2 | M47508 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRNP_PI3K_NOX2_SIGNALING_PATHWAY | 2.60e-03 | 29 | 37 | 2 | M47764 | |
| Pathway | REACTOME_ACTIVATION_OF_G_PROTEIN_GATED_POTASSIUM_CHANNELS | 2.78e-03 | 30 | 37 | 2 | MM14542 | |
| Pathway | WP_THERMOGENESIS | 2.81e-03 | 108 | 37 | 3 | M39746 | |
| Pathway | REACTOME_HSF1_ACTIVATION | 2.97e-03 | 31 | 37 | 2 | M27252 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 3.36e-03 | 115 | 37 | 3 | M9387 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY | 3.36e-03 | 33 | 37 | 2 | M47550 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 3.99e-03 | 36 | 37 | 2 | MM14544 | |
| Pathway | PID_FRA_PATHWAY | 4.21e-03 | 37 | 37 | 2 | M65 | |
| Pathway | KEGG_SPLICEOSOME | 4.44e-03 | 127 | 37 | 3 | M2044 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 5.15e-03 | 134 | 37 | 3 | M3574 | |
| Pathway | WP_OPIOID_RECEPTOR_PATHWAYS | 5.15e-03 | 41 | 37 | 2 | M48338 | |
| Pathway | WP_MEASLES_VIRUS_INFECTION | 5.37e-03 | 136 | 37 | 3 | M42547 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 5.59e-03 | 138 | 37 | 3 | MM15635 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 5.92e-03 | 44 | 37 | 2 | M39845 | |
| Pathway | KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION | 5.92e-03 | 44 | 37 | 2 | M9011 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 5.92e-03 | 44 | 37 | 2 | MM15709 | |
| Pathway | WP_VASOPRESSINREGULATED_WATER_REABSORPTION | 5.92e-03 | 44 | 37 | 2 | M42554 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | ATF7 ASCL4 NR4A3 RHOXF1 ATF3 CAMTA2 NR4A1 SKI ZBTB7B ATF2 HELT CREB5 FOSB FOSL2 BACH1 FOSL1 TBX6 | 1.38e-15 | 908 | 47 | 17 | 19274049 |
| Pubmed | 3.06e-11 | 18 | 47 | 5 | 9858769 | ||
| Pubmed | 8.35e-10 | 33 | 47 | 5 | 20102225 | ||
| Pubmed | Networks of bZIP protein-protein interactions diversified over a billion years of evolution. | 2.30e-09 | 40 | 47 | 5 | 23661758 | |
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 28025138 | ||
| Pubmed | 2.31e-09 | 3 | 47 | 3 | 23352621 | ||
| Pubmed | Stored of Hsp72/Hsp73 in germinal vesicle-stage mouse oocytes. | 2.31e-09 | 3 | 47 | 3 | 15129916 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 2.49e-09 | 544 | 47 | 10 | 28473536 | |
| Pubmed | Delayed temporal increase of hepatic Hsp70 in ApoE knockout mice after prenatal arsenic exposure. | 9.24e-09 | 4 | 47 | 3 | 22956628 | |
| Pubmed | 9.24e-09 | 4 | 47 | 3 | 18379898 | ||
| Pubmed | Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia. | 9.24e-09 | 4 | 47 | 3 | 18299791 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | KANSL3 ATF7 ATF3 TFPT NR4A1 SKI ZBTB7B HSPA1B ATF2 HSPA8 FOSL2 BACH1 FOSL1 | 1.07e-08 | 1294 | 47 | 13 | 30804502 |
| Pubmed | Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. | 2.31e-08 | 5 | 47 | 3 | 16906134 | |
| Pubmed | 2.31e-08 | 5 | 47 | 3 | 17182002 | ||
| Pubmed | Combinatorial bZIP dimers display complex DNA-binding specificity landscapes. | 2.31e-08 | 5 | 47 | 3 | 28186491 | |
| Pubmed | A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. | 2.31e-08 | 5 | 47 | 3 | 11584023 | |
| Pubmed | Heat shock factor 2 is activated during mouse heart development. | 4.61e-08 | 6 | 47 | 3 | 11032181 | |
| Pubmed | Genetic aspects of the hsp70 multigene family in vertebrates. | 4.61e-08 | 6 | 47 | 3 | 7988674 | |
| Pubmed | Phosphorylation and binding partner analysis of the TSC1-TSC2 complex. | 4.61e-08 | 6 | 47 | 3 | 15963462 | |
| Pubmed | 4.61e-08 | 6 | 47 | 3 | 9305631 | ||
| Pubmed | RING finger protein RNF207, a novel regulator of cardiac excitation. | 4.61e-08 | 6 | 47 | 3 | 25281747 | |
| Pubmed | 5.44e-08 | 74 | 47 | 5 | 24952347 | ||
| Pubmed | Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. | 8.06e-08 | 7 | 47 | 3 | 10205060 | |
| Pubmed | c-Jun is required for the specification of joint cell fates. | 8.97e-08 | 31 | 47 | 4 | 23475960 | |
| Pubmed | 8.97e-08 | 31 | 47 | 4 | 20398657 | ||
| Pubmed | Function and regulation of heat shock factor 2 during mouse embryogenesis. | 1.29e-07 | 8 | 47 | 3 | 9122205 | |
| Pubmed | 1.29e-07 | 8 | 47 | 3 | 26747248 | ||
| Pubmed | 1.29e-07 | 8 | 47 | 3 | 21937452 | ||
| Pubmed | 1.93e-07 | 9 | 47 | 3 | 21763498 | ||
| Pubmed | 2.26e-07 | 191 | 47 | 6 | 20195357 | ||
| Pubmed | 2.76e-07 | 10 | 47 | 3 | 7906708 | ||
| Pubmed | Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. | 2.76e-07 | 10 | 47 | 3 | 11932435 | |
| Pubmed | 2.76e-07 | 10 | 47 | 3 | 12832005 | ||
| Pubmed | 2.76e-07 | 10 | 47 | 3 | 23921388 | ||
| Pubmed | ARD1-mediated Hsp70 acetylation balances stress-induced protein refolding and degradation. | 3.79e-07 | 11 | 47 | 3 | 27708256 | |
| Pubmed | 3.79e-07 | 11 | 47 | 3 | 24318877 | ||
| Pubmed | 3.79e-07 | 11 | 47 | 3 | 12220541 | ||
| Pubmed | 5.05e-07 | 12 | 47 | 3 | 12150907 | ||
| Pubmed | HIV-1 viral protein R (Vpr) and its interactions with host cell. | 5.05e-07 | 12 | 47 | 3 | 19275587 | |
| Pubmed | 5.89e-07 | 119 | 47 | 5 | 23508102 | ||
| Pubmed | 6.55e-07 | 13 | 47 | 3 | 30792309 | ||
| Pubmed | UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome. | 6.55e-07 | 13 | 47 | 3 | 27477512 | |
| Pubmed | 1.04e-06 | 15 | 47 | 3 | 10964507 | ||
| Pubmed | 1.10e-06 | 57 | 47 | 4 | 34003106 | ||
| Pubmed | Clathrin facilitates the morphogenesis of retrovirus particles. | 1.28e-06 | 16 | 47 | 3 | 21738476 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 20581861 | ||
| Pubmed | Exercise induces hepatosplanchnic release of heat shock protein 72 in humans. | 1.79e-06 | 2 | 47 | 2 | 12411538 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 2868009 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 25618331 | ||
| Pubmed | Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients. | 1.79e-06 | 2 | 47 | 2 | 24328534 | |
| Pubmed | Immunoreactivity of ATF-2 and Fra-2 in human dental follicle. | 1.79e-06 | 2 | 47 | 2 | 20675274 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 3786141 | ||
| Pubmed | Extracellular heat shock protein 72 is a marker of the stress protein response in acute lung injury. | 1.79e-06 | 2 | 47 | 2 | 16679378 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 19639652 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 16100242 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 15498567 | ||
| Pubmed | Biological activity of truncated C-terminus human heat shock protein 72. | 1.79e-06 | 2 | 47 | 2 | 21094186 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 7813466 | ||
| Pubmed | Characterization of the binding between a 70-kDa heat shock protein, HspA1A, and phosphoinositides. | 1.79e-06 | 2 | 47 | 2 | 26923070 | |
| Pubmed | The orphan nuclear receptor Nor1/Nr4a3 is a negative regulator of β-cell mass. | 1.79e-06 | 2 | 47 | 2 | 30696767 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 16482515 | ||
| Pubmed | Geranylgeranylaceton induces heat shock protein 72 in skeletal muscle cells. | 1.79e-06 | 2 | 47 | 2 | 17482577 | |
| Pubmed | Effect of hyaluronan oligosaccharides on the expression of heat shock protein 72. | 1.79e-06 | 2 | 47 | 2 | 11864979 | |
| Pubmed | Structure and expression of an inducible HSP70-encoding gene from Mus musculus. | 1.79e-06 | 2 | 47 | 2 | 8076831 | |
| Pubmed | The 70 kDa heat shock protein protects against experimental traumatic brain injury. | 1.79e-06 | 2 | 47 | 2 | 23816752 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 20411565 | ||
| Pubmed | NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes. | 1.79e-06 | 2 | 47 | 2 | 28249906 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 20668010 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 15719414 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 26976620 | ||
| Pubmed | Targeting membrane heat-shock protein 70 (Hsp70) on tumors by cmHsp70.1 antibody. | 1.79e-06 | 2 | 47 | 2 | 21187371 | |
| Pubmed | Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer. | 1.79e-06 | 2 | 47 | 2 | 20430459 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 20235222 | ||
| Pubmed | The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms. | 1.79e-06 | 2 | 47 | 2 | 25410408 | |
| Pubmed | Genetic determinants of HSP70 gene expression following heat shock. | 1.79e-06 | 2 | 47 | 2 | 20876613 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 20223214 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 38776730 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 12840151 | ||
| Pubmed | Structure of a new crystal form of human Hsp70 ATPase domain. | 1.79e-06 | 2 | 47 | 2 | 10216320 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 21308712 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 20093776 | ||
| Pubmed | Bacterial infection elicits heat shock protein 72 release from pleural mesothelial cells. | 1.79e-06 | 2 | 47 | 2 | 23704948 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 14672969 | ||
| Pubmed | Structure and expression of the human gene encoding major heat shock protein HSP70. | 1.79e-06 | 2 | 47 | 2 | 2858050 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 17513788 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 19153266 | ||
| Pubmed | IL-6 activates HSP72 gene expression in human skeletal muscle. | 1.79e-06 | 2 | 47 | 2 | 12207910 | |
| Pubmed | Genetic Modulation of HSPA1A Accelerates Kindling Progression and Exerts Pro-convulsant Effects. | 1.79e-06 | 2 | 47 | 2 | 29964156 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 28837204 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 3019832 | ||
| Pubmed | Sequence analysis of HSPA1A and HSPA1B in a multi-ethnic study population. | 1.79e-06 | 2 | 47 | 2 | 17364813 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 24430435 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 22940431 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 29572464 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 15988927 | ||
| Pubmed | The role of heat shock protein 70 in mediating age-dependent mortality in sepsis. | 1.79e-06 | 2 | 47 | 2 | 21296977 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 23247046 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 17617616 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 26448330 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 29323151 | ||
| Interaction | ATF7 interactions | 1.58e-14 | 63 | 46 | 9 | int:ATF7 | |
| Interaction | JUNB interactions | 2.35e-10 | 118 | 46 | 8 | int:JUNB | |
| Interaction | BATF3 interactions | 2.40e-09 | 54 | 46 | 6 | int:BATF3 | |
| Interaction | JUND interactions | 2.47e-08 | 79 | 46 | 6 | int:JUND | |
| Interaction | SRA1 interactions | 3.33e-08 | 83 | 46 | 6 | int:SRA1 | |
| Interaction | ATF2 interactions | 7.94e-08 | 247 | 46 | 8 | int:ATF2 | |
| Interaction | JUN interactions | 8.31e-08 | 470 | 46 | 10 | int:JUN | |
| Interaction | CREB5 interactions | 8.52e-08 | 164 | 46 | 7 | int:CREB5 | |
| Interaction | DDIT3 interactions | 3.03e-07 | 120 | 46 | 6 | int:DDIT3 | |
| Interaction | CEBPG interactions | 3.69e-07 | 65 | 46 | 5 | int:CEBPG | |
| Interaction | FOSL1 interactions | 5.37e-07 | 70 | 46 | 5 | int:FOSL1 | |
| Interaction | DNMT3L interactions | 1.68e-06 | 88 | 46 | 5 | int:DNMT3L | |
| Interaction | BACH2 interactions | 1.88e-06 | 90 | 46 | 5 | int:BACH2 | |
| Interaction | FOSB interactions | 4.67e-06 | 49 | 46 | 4 | int:FOSB | |
| Interaction | FOS interactions | 6.36e-06 | 312 | 46 | 7 | int:FOS | |
| Interaction | ATF1 interactions | 1.45e-05 | 65 | 46 | 4 | int:ATF1 | |
| Interaction | OSBPL10 interactions | 1.95e-05 | 70 | 46 | 4 | int:OSBPL10 | |
| Interaction | CCDC117 interactions | 2.79e-05 | 26 | 46 | 3 | int:CCDC117 | |
| Interaction | GNAS interactions | 2.88e-05 | 264 | 46 | 6 | int:GNAS | |
| Interaction | FOSL2 interactions | 3.83e-05 | 83 | 46 | 4 | int:FOSL2 | |
| Interaction | ATF3 interactions | 6.23e-05 | 94 | 46 | 4 | int:ATF3 | |
| Interaction | METTL21A interactions | 7.54e-05 | 36 | 46 | 3 | int:METTL21A | |
| Interaction | FAM83F interactions | 7.54e-05 | 36 | 46 | 3 | int:FAM83F | |
| Interaction | SPOPL interactions | 8.19e-05 | 37 | 46 | 3 | int:SPOPL | |
| Interaction | RNF207 interactions | 1.06e-04 | 7 | 46 | 2 | int:RNF207 | |
| Interaction | CENPQ interactions | 1.07e-04 | 108 | 46 | 4 | int:CENPQ | |
| Interaction | BACH1 interactions | 1.19e-04 | 111 | 46 | 4 | int:BACH1 | |
| Interaction | JDP2 interactions | 1.20e-04 | 42 | 46 | 3 | int:JDP2 | |
| Interaction | TRIB1 interactions | 1.58e-04 | 46 | 46 | 3 | int:TRIB1 | |
| Interaction | HDAC10 interactions | 1.58e-04 | 46 | 46 | 3 | int:HDAC10 | |
| Interaction | KCNH2 interactions | 1.58e-04 | 46 | 46 | 3 | int:KCNH2 | |
| Interaction | HDAC1 interactions | ATF3 NR4A1 CLP1 ZBTB7B HSPA1A HSPA1B KDM4C HSPA8 BACH1 FOSL1 | 1.61e-04 | 1108 | 46 | 10 | int:HDAC1 |
| Interaction | TRIM38 interactions | 1.68e-04 | 47 | 46 | 3 | int:TRIM38 | |
| Interaction | CCNI2 interactions | 1.82e-04 | 9 | 46 | 2 | int:CCNI2 | |
| Interaction | MAFF interactions | 1.91e-04 | 49 | 46 | 3 | int:MAFF | |
| Interaction | CCDC142 interactions | 2.27e-04 | 10 | 46 | 2 | int:CCDC142 | |
| Interaction | IRF2BPL interactions | 2.41e-04 | 53 | 46 | 3 | int:IRF2BPL | |
| Interaction | HEY2 interactions | 2.69e-04 | 55 | 46 | 3 | int:HEY2 | |
| Interaction | DRD5 interactions | 2.77e-04 | 11 | 46 | 2 | int:DRD5 | |
| Interaction | STK40 interactions | 3.14e-04 | 58 | 46 | 3 | int:STK40 | |
| Interaction | AR interactions | 3.48e-04 | 992 | 46 | 9 | int:AR | |
| Interaction | LRRC28 interactions | 3.91e-04 | 13 | 46 | 2 | int:LRRC28 | |
| Interaction | CFAP52 interactions | 3.91e-04 | 13 | 46 | 2 | int:CFAP52 | |
| Interaction | KRTAP10-1 interactions | 4.07e-04 | 153 | 46 | 4 | int:KRTAP10-1 | |
| Interaction | NNMT interactions | 4.56e-04 | 14 | 46 | 2 | int:NNMT | |
| Interaction | VILL interactions | 4.56e-04 | 14 | 46 | 2 | int:VILL | |
| Interaction | NFE2L2 interactions | 4.70e-04 | 159 | 46 | 4 | int:NFE2L2 | |
| Interaction | GPRC5A interactions | 5.03e-04 | 68 | 46 | 3 | int:GPRC5A | |
| Interaction | CAVIN1 interactions | 5.20e-04 | 292 | 46 | 5 | int:CAVIN1 | |
| Interaction | TBX3 interactions | 5.25e-04 | 69 | 46 | 3 | int:TBX3 | |
| Interaction | CYP2W1 interactions | 5.25e-04 | 15 | 46 | 2 | int:CYP2W1 | |
| Interaction | AHCY interactions | 5.28e-04 | 293 | 46 | 5 | int:AHCY | |
| Interaction | MVP interactions | 5.79e-04 | 168 | 46 | 4 | int:MVP | |
| Interaction | NFATC1 interactions | 5.79e-04 | 168 | 46 | 4 | int:NFATC1 | |
| Interaction | PPP2R2D interactions | 5.79e-04 | 168 | 46 | 4 | int:PPP2R2D | |
| Interaction | INSYN1 interactions | 5.92e-04 | 169 | 46 | 4 | int:INSYN1 | |
| Interaction | SETD1A interactions | 6.05e-04 | 170 | 46 | 4 | int:SETD1A | |
| Interaction | SENP2 interactions | 6.19e-04 | 171 | 46 | 4 | int:SENP2 | |
| Interaction | PRKCE interactions | 6.46e-04 | 173 | 46 | 4 | int:PRKCE | |
| Interaction | GNB1 interactions | 6.53e-04 | 307 | 46 | 5 | int:GNB1 | |
| Interaction | C3orf38 interactions | 6.78e-04 | 17 | 46 | 2 | int:C3orf38 | |
| Interaction | MBLAC1 interactions | 6.78e-04 | 17 | 46 | 2 | int:MBLAC1 | |
| GeneFamily | Basic leucine zipper proteins | 5.81e-14 | 49 | 37 | 8 | 506 | |
| GeneFamily | Basic leucine zipper proteins|Fos transcription factor family | 3.15e-08 | 4 | 37 | 3 | 1256 | |
| GeneFamily | Heat shock 70kDa proteins | 5.26e-06 | 17 | 37 | 3 | 583 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 4.80e-04 | 16 | 37 | 2 | 276 | |
| GeneFamily | Nuclear hormone receptors | 4.51e-03 | 49 | 37 | 2 | 71 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_BASAL_CELL_AGEING | 2.36e-10 | 322 | 47 | 10 | MM3786 | |
| Coexpression | JIANG_MELANOMA_TRM1_CD8 | 9.27e-10 | 177 | 47 | 8 | M48965 | |
| Coexpression | JIANG_MELANOMA_TRM2_CD8 | 7.51e-09 | 146 | 47 | 7 | M48966 | |
| Coexpression | GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP | 9.07e-09 | 150 | 47 | 7 | M8796 | |
| Coexpression | NAGASHIMA_EGF_SIGNALING_UP | 5.81e-08 | 57 | 47 | 5 | M16311 | |
| Coexpression | GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP | 2.70e-07 | 149 | 47 | 6 | M8786 | |
| Coexpression | GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP | 3.16e-07 | 153 | 47 | 6 | M8789 | |
| Coexpression | UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN | 5.12e-07 | 36 | 47 | 4 | M9162 | |
| Coexpression | KRISHNAN_FURIN_TARGETS_UP | 6.43e-07 | 10 | 47 | 3 | MM1243 | |
| Coexpression | JIANG_MELANOMA_TRM5_CD8 | 1.09e-06 | 189 | 47 | 6 | M48969 | |
| Coexpression | GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP | 1.35e-06 | 196 | 47 | 6 | M4930 | |
| Coexpression | GSE23695_CD57_POS_VS_NEG_NK_CELL_DN | 1.52e-06 | 200 | 47 | 6 | M7786 | |
| Coexpression | HALLMARK_TNFA_SIGNALING_VIA_NFKB | 1.52e-06 | 200 | 47 | 6 | M5890 | |
| Coexpression | AMIT_EGF_RESPONSE_60_HELA | 1.53e-06 | 47 | 47 | 4 | M10797 | |
| Coexpression | CHEN_HOXA5_TARGETS_9HR_UP | 2.85e-06 | 223 | 47 | 6 | M17621 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_LUMINAL_EPITHELIAL_CELL_OF_MAMMARY_GLAND_AGEING | 2.94e-06 | 352 | 47 | 7 | MM3788 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 3.34e-06 | 57 | 47 | 4 | MM3716 | |
| Coexpression | AMIT_DELAYED_EARLY_GENES | 4.33e-06 | 18 | 47 | 3 | M10550 | |
| Coexpression | GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP | 5.00e-06 | 139 | 47 | 5 | M11672 | |
| Coexpression | TIAN_TNF_SIGNALING_NOT_VIA_NFKB | 8.12e-06 | 22 | 47 | 3 | M14666 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 8.51e-06 | 155 | 47 | 5 | M39246 | |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP | 1.33e-05 | 170 | 47 | 5 | M6697 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_UP | 1.36e-05 | 445 | 47 | 7 | M7928 | |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 1.36e-05 | 26 | 47 | 3 | M1380 | |
| Coexpression | DALESSIO_TSA_RESPONSE | 1.36e-05 | 26 | 47 | 3 | M2340 | |
| Coexpression | NAGASHIMA_NRG1_SIGNALING_UP | 1.41e-05 | 172 | 47 | 5 | M11585 | |
| Coexpression | GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP | 2.00e-05 | 185 | 47 | 5 | M8792 | |
| Coexpression | GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_DN | 2.33e-05 | 191 | 47 | 5 | M8802 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5 | 2.58e-05 | 32 | 47 | 3 | MM1278 | |
| Coexpression | AMIT_SERUM_RESPONSE_40_MCF10A | 2.58e-05 | 32 | 47 | 3 | M11519 | |
| Coexpression | NOJIMA_SFRP2_TARGETS_UP | 2.58e-05 | 32 | 47 | 3 | M14772 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_MESENCHYMAL_STEM_CELL_AGEING | 2.64e-05 | 196 | 47 | 5 | MM3746 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_BLADDER_CELL_AGEING | 2.74e-05 | 332 | 47 | 6 | MM3679 | |
| Coexpression | GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP | 2.84e-05 | 199 | 47 | 5 | M7885 | |
| Coexpression | GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_UP | 2.91e-05 | 200 | 47 | 5 | M7783 | |
| Coexpression | BROWNE_HCMV_INFECTION_2HR_UP | 5.10e-05 | 40 | 47 | 3 | M3649 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_AIRWAY_SMC_CELL | 5.42e-05 | 115 | 47 | 4 | M45671 | |
| Coexpression | FAN_OVARY_CL17_PUTATIVE_APOPTOTIC_SMOOTH_MUSCLE_CELL | 5.78e-05 | 231 | 47 | 5 | M41719 | |
| Coexpression | ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF | 5.90e-05 | 232 | 47 | 5 | M2613 | |
| Coexpression | AMIT_EGF_RESPONSE_40_HELA | 5.91e-05 | 42 | 47 | 3 | M4204 | |
| Coexpression | VANASSE_BCL2_TARGETS_UP | 6.34e-05 | 43 | 47 | 3 | MM799 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 6.92e-05 | 240 | 47 | 5 | M39236 | |
| Coexpression | AIZARANI_LIVER_C12_NK_NKT_CELLS_4 | 9.40e-05 | 49 | 47 | 3 | M39116 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_DN | 1.01e-04 | 260 | 47 | 5 | M41075 | |
| Coexpression | ZHANG_UTERUS_C6_ENDOTHELIAL_PLVAP_HIGH_CELL | 1.07e-04 | 137 | 47 | 4 | MM16612 | |
| Coexpression | CUI_DEVELOPING_HEART_VALVAR_ENDOTHELIAL_CELL | 1.13e-04 | 139 | 47 | 4 | M39322 | |
| Coexpression | TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_2_CELL | 1.25e-04 | 272 | 47 | 5 | M41669 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 1.33e-04 | 276 | 47 | 5 | M41128 | |
| Coexpression | KRISHNAN_FURIN_TARGETS_UP | 1.40e-04 | 10 | 47 | 2 | M15228 | |
| Coexpression | PODAR_RESPONSE_TO_ADAPHOSTIN_UP | 1.44e-04 | 148 | 47 | 4 | M16336 | |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP | 1.50e-04 | 452 | 47 | 6 | M18685 | |
| Coexpression | FAN_OVARY_CL6_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_2 | 1.97e-04 | 300 | 47 | 5 | M41708 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 2.24e-04 | 166 | 47 | 4 | M1542 | |
| Coexpression | MA_RAT_AGING_DN | 2.45e-04 | 170 | 47 | 4 | MM16097 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP | 2.68e-04 | 174 | 47 | 4 | M34014 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 2.76e-04 | 323 | 47 | 5 | M9150 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | 2.79e-04 | 721 | 47 | 7 | M1999 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 2.86e-04 | 177 | 47 | 4 | M39245 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 2.98e-04 | 179 | 47 | 4 | MM660 | |
| Coexpression | GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN | 3.24e-04 | 183 | 47 | 4 | M7627 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN | 3.24e-04 | 183 | 47 | 4 | M8886 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | 3.28e-04 | 1250 | 47 | 9 | M41099 | |
| Coexpression | AIZARANI_LIVER_C39_EPCAM_POS_BILE_DUCT_CELLS_4 | 3.31e-04 | 184 | 47 | 4 | M39135 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_DN | 3.60e-04 | 77 | 47 | 3 | M34011 | |
| Coexpression | FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP | 3.72e-04 | 16 | 47 | 2 | MM559 | |
| Coexpression | GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_DN | 3.74e-04 | 190 | 47 | 4 | M384 | |
| Coexpression | GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN | 3.74e-04 | 190 | 47 | 4 | M8457 | |
| Coexpression | GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP | 3.81e-04 | 191 | 47 | 4 | M4926 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 3.97e-04 | 193 | 47 | 4 | M39321 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 4.05e-04 | 194 | 47 | 4 | M7306 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP | 4.09e-04 | 545 | 47 | 6 | M34016 | |
| Coexpression | GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP | 4.29e-04 | 197 | 47 | 4 | M5867 | |
| Coexpression | GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_UP | 4.37e-04 | 198 | 47 | 4 | M5083 | |
| Coexpression | GSE45365_NK_CELL_VS_BCELL_UP | 4.37e-04 | 198 | 47 | 4 | M10031 | |
| Coexpression | GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN | 4.45e-04 | 199 | 47 | 4 | M3502 | |
| Coexpression | GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_DN | 4.45e-04 | 199 | 47 | 4 | M6488 | |
| Coexpression | GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN | 4.45e-04 | 199 | 47 | 4 | M5221 | |
| Coexpression | GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN | 4.45e-04 | 199 | 47 | 4 | M9751 | |
| Coexpression | GSE17721_CTRL_VS_LPS_1H_BMDC_DN | 4.45e-04 | 199 | 47 | 4 | M3685 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 4.45e-04 | 199 | 47 | 4 | M9184 | |
| Coexpression | GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_DN | 4.54e-04 | 200 | 47 | 4 | M7790 | |
| Coexpression | GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN | 4.54e-04 | 200 | 47 | 4 | M5364 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN | 4.54e-04 | 200 | 47 | 4 | M5156 | |
| Coexpression | GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN | 4.54e-04 | 200 | 47 | 4 | M3499 | |
| Coexpression | GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN | 4.54e-04 | 200 | 47 | 4 | M3497 | |
| Coexpression | GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_DN | 4.54e-04 | 200 | 47 | 4 | M7884 | |
| Coexpression | GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN | 4.54e-04 | 200 | 47 | 4 | M7269 | |
| Coexpression | GSE3982_DC_VS_NKCELL_UP | 4.54e-04 | 200 | 47 | 4 | M5478 | |
| Coexpression | GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP | 4.54e-04 | 200 | 47 | 4 | M3675 | |
| Coexpression | LEE_AGING_CEREBELLUM_UP | 4.65e-04 | 84 | 47 | 3 | M1599 | |
| Coexpression | JIANG_MELANOMA_TRM4 | 4.80e-04 | 203 | 47 | 4 | M48968 | |
| Coexpression | CUI_DEVELOPING_HEART_C5_VALVAR_CELL | 4.98e-04 | 205 | 47 | 4 | M39302 | |
| Coexpression | ALCALA_APOPTOSIS | 5.15e-04 | 87 | 47 | 3 | M16169 | |
| Coexpression | LEE_AGING_CEREBELLUM_UP | 5.15e-04 | 87 | 47 | 3 | MM1023 | |
| Coexpression | FEKIR_HEPARG_SIDE_POP_VS_HEPARG_UP | 5.69e-04 | 90 | 47 | 3 | M48360 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_DENDRITIC_CELLS | 5.85e-04 | 214 | 47 | 4 | M40005 | |
| Coexpression | LAMB_CCND1_TARGETS | 5.86e-04 | 20 | 47 | 2 | M2935 | |
| Coexpression | UNTERMAN_IPF_VS_CTRL_MONOCYTE_DN | 5.86e-04 | 20 | 47 | 2 | M48278 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_VASCULAR_SMOOTH_MUSCLE_CELLS | 6.26e-04 | 93 | 47 | 3 | M39279 | |
| Coexpression | GESERICK_TERT_TARGETS_DN | 6.47e-04 | 21 | 47 | 2 | M15891 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#2_top-relative-expression-ranked_100 | 5.74e-09 | 11 | 45 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_100_k2 | |
| CoexpressionAtlas | EB BM CD34+_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.99e-08 | 82 | 45 | 6 | PCBC_ratio_EB BM CD34+_vs_EB blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#4_top-relative-expression-ranked_200 | 2.36e-08 | 15 | 45 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#1_top-relative-expression-ranked_200 | 1.25e-07 | 22 | 45 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200_k1 | |
| CoexpressionAtlas | Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2 | 1.38e-06 | 91 | 45 | 5 | GSM538280_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_200 | 1.41e-06 | 168 | 45 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_500 | 1.76e-06 | 401 | 45 | 8 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+24-.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24-, Lung, avg-2 | 2.24e-06 | 414 | 45 | 8 | GSM854271_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.LC.Sk, MHCII+ CD11b+ CD45+, Skin, avg-2 | 4.21e-06 | 451 | 45 | 8 | GSM538280_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#4_top-relative-expression-ranked_500 | 4.78e-06 | 53 | 45 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_1000 | NR4A3 ATF3 CAPN5 NR4A1 PSAPL1 HSPA1A HSPA1B FOSB FOSL2 FOSL1 | 5.25e-06 | 800 | 45 | 10 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.11cloSer.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-lo CD11b+, Small Intestine, avg-4 | 1.06e-05 | 364 | 45 | 7 | GSM854276_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b+.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-hi CD11b+ CD103+ F480-, Small Intestine, avg-5 | 1.38e-05 | 379 | 45 | 7 | GSM854232_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3 | 1.50e-05 | 384 | 45 | 7 | GSM605820_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5-.IEL, CD8a+ CD8b- TCRgd+ Vg5- CD44lo, Small Intestine, avg-3 | 2.12e-05 | 405 | 45 | 7 | GSM605811_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2 | 2.26e-05 | 409 | 45 | 7 | GSM538234_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3 | 2.26e-05 | 409 | 45 | 7 | GSM605823_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3 | 2.33e-05 | 411 | 45 | 7 | GSM538239_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2 | 2.60e-05 | 81 | 45 | 4 | GSM538234_100 | |
| CoexpressionAtlas | Embryoid Body Cells-reprogram_OSK-L-l-p53KD_vs_Embryoid Body Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 2.86e-05 | 83 | 45 | 4 | PCBC_ratio_EB_from-OSK-L-l-p53KD_vs_EB_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#1_top-relative-expression-ranked_500 | 3.13e-05 | 29 | 45 | 3 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k1_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_100 | 3.45e-05 | 87 | 45 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_100 | 4.11e-05 | 91 | 45 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.61e-05 | 187 | 45 | 5 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#2_top-relative-expression-ranked_500 | 5.07e-05 | 96 | 45 | 4 | gudmap_developingLowerUrinaryTract_P1_ureter_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.03e-05 | 108 | 45 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#4_top-relative-expression-ranked_100 | 9.16e-05 | 7 | 45 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_100_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.53e-05 | 218 | 45 | 5 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k3 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.SI, CD45+ MHCII+ CD11c-hi CD103+ CD11b-, Small Intestine, avg-4 | 1.27e-04 | 372 | 45 | 6 | GSM854251_500 | |
| CoexpressionAtlas | EB amniotic fluid MSC_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.27e-04 | 727 | 45 | 8 | PCBC_ratio_EB amniotic fluid MSC_vs_EB blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.LN, F480+ Ly6c+ MHCII lo/+, Lymph Node, avg-3 | 1.31e-04 | 374 | 45 | 6 | GSM605875_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b+.SI, CD45+ MHCII+ CD11c-hi CD11b+ CD103+ F4/80-lo, Small Intestine, avg-4 | 1.33e-04 | 375 | 45 | 6 | GSM854237_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-hi CD103+ CD11b-, Small Intestine, avg-5 | 1.43e-04 | 380 | 45 | 6 | GSM854246_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#5_top-relative-expression-ranked_500 | 1.63e-04 | 50 | 45 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_500 | 1.67e-04 | 391 | 45 | 6 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lu, MHCII+ CD11c+ CD103+ CD11b, Lung, avg-2 | 1.94e-04 | 402 | 45 | 6 | GSM854241_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Lv, CD45+ F4/80+ CD11b+, Liver, avg-2 | 1.94e-04 | 402 | 45 | 6 | GSM854320_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+24+.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24+, Lung, avg-2 | 1.99e-04 | 404 | 45 | 6 | GSM854269_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#4_top-relative-expression-ranked_500 | 2.05e-04 | 54 | 45 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_500_k4 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg5+.IEL, CD8a+ CD8b- TCRd+ Vg5+ CD44lo, Small Intestine, avg-3 | 2.30e-04 | 415 | 45 | 6 | GSM605805_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b+.SI, CD45+ MHCII+ CD11c-hi CD11b+ CD103+ F4/80-lo, Small Intestine, avg-4 | 2.53e-04 | 58 | 45 | 3 | GSM854237_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lu, CD11chi CD11b low CD103+ MHCII+ SiglecF-, Lung, avg-3 | 2.58e-04 | 424 | 45 | 6 | GSM538231_500 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K2 | 2.58e-04 | 270 | 45 | 5 | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.86e-04 | 276 | 45 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000_k3 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_500 | 3.08e-04 | 62 | 45 | 3 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.72e-04 | 161 | 45 | 4 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k5 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 3.94e-04 | 459 | 45 | 6 | GSM777037_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b+.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-hi CD11b+ CD103+ F480-, Small Intestine, avg-5 | 4.23e-04 | 69 | 45 | 3 | GSM854232_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_200 | 4.28e-04 | 167 | 45 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_200 | |
| CoexpressionAtlas | kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_StemCellamp_k-means-cluster#3_top-relative-expression-ranked_100 | 4.53e-04 | 15 | 45 | 2 | gudmap_kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_Scamp_k3_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-hi CD103+ CD11b-, Small Intestine, avg-5 | 4.79e-04 | 72 | 45 | 3 | GSM854246_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#1_top-relative-expression-ranked_200 | 5.17e-04 | 16 | 45 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200_k1 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.19e-04 | 74 | 45 | 3 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k4_1000 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+24+.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24+, Lung, avg-2 | 5.40e-04 | 75 | 45 | 3 | GSM854269_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_500 | 5.40e-04 | 75 | 45 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_J_500_k1 | |
| CoexpressionAtlas | alpha beta T cells, T.4.Sp.B16, 4+ 8- TCR+ 45+, B16 Melanoma Spleen, avg-2 | 5.78e-04 | 322 | 45 | 5 | GSM605761_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3 | 6.05e-04 | 78 | 45 | 3 | GSM605820_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3 | 6.76e-04 | 81 | 45 | 3 | GSM605823_100 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K0 | 6.86e-04 | 711 | 45 | 7 | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K0 | |
| CoexpressionAtlas | alpha beta T cells, T.4.PLN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | 7.00e-04 | 336 | 45 | 5 | GSM605758_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103+11b-.Lu, MHCII+ CD11c+ CD103+ CD11b, Lung, avg-2 | 7.26e-04 | 83 | 45 | 3 | GSM854241_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#5_top-relative-expression-ranked_500 | 7.37e-04 | 193 | 45 | 4 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k5_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4Mem44h62l.LN, CD4 TCRb CD44hi CD62Llo, Lymph Node, avg-3 | 7.99e-04 | 346 | 45 | 5 | GSM538368_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 8.32e-04 | 87 | 45 | 3 | GSM777050_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_100 | 9.79e-04 | 92 | 45 | 3 | gudmap_dev gonad_e11.5_F_GonMes_Sma_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_100 | 9.79e-04 | 92 | 45 | 3 | gudmap_dev gonad_e11.5_M_GonMes_Sma_100 | |
| CoexpressionAtlas | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K1 | 9.86e-04 | 987 | 45 | 8 | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K1 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.LuLN, MHCII+ CD11c+ CD8- CD11b+ CD103-, Lymph Node, avg-3 | 1.03e-03 | 366 | 45 | 5 | GSM854255_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-hi CD11b+ CD103- F480+, Small Intestine, avg-4 | 1.05e-03 | 368 | 45 | 5 | GSM854258_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#4_top-relative-expression-ranked_500 | 1.14e-03 | 217 | 45 | 4 | gudmap_developingKidney_e15.5_Endothelial cells_500_k4 | |
| CoexpressionAtlas | Myeloid Cells, DC.11cloSer.SI, CD45+ MHCII+ CD11c-lo CD11b+, Small Intestine, avg-5 | 1.17e-03 | 377 | 45 | 5 | GSM854280_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_100 | 1.18e-03 | 24 | 45 | 2 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k2_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | 1.18e-03 | 780 | 45 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+.SI, CD45+ MHCII+ CD11c-hi CD11b+ CD103- F4/80+, Small Intestine, avg-7 | 1.23e-03 | 381 | 45 | 5 | GSM854262_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.4+.Sp, CD11b CD4 CD45 CD11c CD8a, Spleen, avg-1 | 1.26e-03 | 383 | 45 | 5 | GSM605826_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_top-relative-expression-ranked_500 | 1.27e-03 | 384 | 45 | 5 | gudmap_developingKidney_e15.5_Endothelial cells_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_500 | 1.27e-03 | 384 | 45 | 5 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.28e-03 | 101 | 45 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k2 | |
| CoexpressionAtlas | alpha beta T cells, NKT.44+NK1.1+.Th, aGC CD1d tet CD3e CD44 NK1.1, Thymus, avg-3 | 1.29e-03 | 385 | 45 | 5 | GSM538332_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.30e-03 | 225 | 45 | 4 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.46e-03 | 232 | 45 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_1000_k3 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_200 | 1.49e-03 | 27 | 45 | 2 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k3_200 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-IIint.Bl, CD115+ B220- CD43- Ly6C- MHCIIint, Blood, avg-5 | 1.52e-03 | 400 | 45 | 5 | GSM605886_500 | |
| CoexpressionAtlas | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1 | 1.56e-03 | 402 | 45 | 5 | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K1 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II-.Bl, CD115+ B220- CD43- Ly6C- MHCII-, Blood, avg-3 | 1.56e-03 | 402 | 45 | 5 | GSM605883_500 | |
| CoexpressionAtlas | kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_StemCellamp_k-means-cluster#1_top-relative-expression-ranked_200 | 1.60e-03 | 28 | 45 | 2 | gudmap_kidney single cell_adult_JuxtaGlomCell_Ren1Gfp_Scamp_k1_200 | |
| CoexpressionAtlas | Myeloid Cells, MF.Microglia.CNS, CD45low CD11b+ F4/80+, Brain, avg-3 | 1.62e-03 | 406 | 45 | 5 | GSM854326_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | 1.65e-03 | 827 | 45 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II+.Bl, CD115+ B220- CD43+ Ly6C+ MHCIIint, Blood, avg-4 | 1.66e-03 | 408 | 45 | 5 | GSM605868_500 | |
| CoexpressionAtlas | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K4 | 1.71e-03 | 1337 | 45 | 9 | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_100 | 1.72e-03 | 29 | 45 | 2 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k4_100 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_200 | 1.72e-03 | 29 | 45 | 2 | gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k4_200 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-2 | 1.75e-03 | 413 | 45 | 5 | GSM538263_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-.Th, CD11b-FITC CD4-PE MHCII-APC CD11c-eFluor780 CD8-eF, Thymus, avg-3 | 1.75e-03 | 413 | 45 | 5 | GSM605831_500 | |
| CoexpressionAtlas | adrenal gland | 1.83e-03 | 247 | 45 | 4 | adrenal gland | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 1.84e-03 | 30 | 45 | 2 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k4_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 1.84e-03 | 30 | 45 | 2 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_200 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-3 | 1.85e-03 | 418 | 45 | 5 | GSM605836_500 | |
| CoexpressionAtlas | Myeloid Cells, GN.Arth.SynF, CD11b+ Ly6-G+, Synovial Fluid, avg-3 | 1.85e-03 | 418 | 45 | 5 | GSM854338_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.SLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-2 | 1.86e-03 | 419 | 45 | 5 | GSM854285_500 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.83e-13 | 193 | 47 | 9 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-11 | 184 | 47 | 8 | 780d67f04fc795f614e077d8a5cf368542f6d99d | |
| ToppCell | facs-Trachea|facs / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-11 | 196 | 47 | 8 | 34020d6553309daa269dff05de0a8567211ea4d2 | |
| ToppCell | facs-Trachea|facs / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.06e-11 | 196 | 47 | 8 | 8209f2b0f7efebaaf81d642d18a1aee8a9a8dcf6 | |
| ToppCell | normal_Lung-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.31e-11 | 198 | 47 | 8 | fbd72ebaba73cc30e79dc8a8c3d46b6f863c1494 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-11 | 198 | 47 | 8 | ec115c4a5dbc54206c72140aa0c8d6a7c29c5563 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.60e-10 | 171 | 47 | 7 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | Monocytes-IL1B+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.71e-10 | 185 | 47 | 7 | cbe54b605f417a01b3b5d2ec75565ee3b5a9ba06 | |
| ToppCell | facs-Limb_Muscle|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-09 | 189 | 47 | 7 | 21ec43859d21ffc565acbe36489da1d2d0f9877d | |
| ToppCell | ILEUM|World / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.17e-09 | 190 | 47 | 7 | 4395dbd18c14d491f5066a2ddac438a16b1fd7c3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-09 | 192 | 47 | 7 | c47df468cf78a90929913c9022e8078a53cdf680 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.26e-09 | 192 | 47 | 7 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.26e-09 | 192 | 47 | 7 | 3f925a80b5e2b0577d573e88598a2984a5f6a789 | |
| ToppCell | 368C-Myeloid-Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-09 | 194 | 47 | 7 | f9b9cbd1a418a7cbd151c2425fda6b864db9aa82 | |
| ToppCell | PBMC-Severe-cDC_5|Severe / Compartment, Disease Groups and Clusters | 1.35e-09 | 194 | 47 | 7 | b903e23eb75733ca516770727097fe74a9f8c1d1 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC2|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-09 | 194 | 47 | 7 | aa6c9b71006fd3863a802d112d9c3838865a52bf | |
| ToppCell | 343B-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-09 | 195 | 47 | 7 | d1ec768573929c717bb6b20ad5f26c4549cfcaed | |
| ToppCell | 343B-Myeloid-Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-09 | 195 | 47 | 7 | ff87a33f9a48765bfa9408f686985feefeff2adf | |
| ToppCell | 343B-Myeloid-Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-09 | 195 | 47 | 7 | 169b4952118ca5ded55de928a1cf08721cdac193 | |
| ToppCell | Mesenchymal_cells-Myofibroblasts|World / Lineage and Cell class | 1.45e-09 | 196 | 47 | 7 | 2c0f429ae18c2df05c33ddf58dcc2c94b819b9a1 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-09 | 197 | 47 | 7 | cd54e6ad175529327fa0372033016b3b978dd452 | |
| ToppCell | 343B-Myeloid-Monocyte-CD16+_Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.50e-09 | 197 | 47 | 7 | 8d6551e118cfe308088487c6d5171d986f90fb2f | |
| ToppCell | 356C-Myeloid-Monocyte-CD14+_Monocyte|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-09 | 198 | 47 | 7 | 8f53df66712c0b4a176098c0dbb3c2c13d3f56df | |
| ToppCell | 356C-Myeloid-Monocyte|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-09 | 198 | 47 | 7 | ad5b9a92f3ad7f4220f173cee4dba0977bd803fe | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.61e-09 | 199 | 47 | 7 | 0d1f2b0d10c1f8ee10c448659b2a22ea0a6a6f0d | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Mast_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-09 | 200 | 47 | 7 | 21de2cf284c8d2aa464f3d403f0e292e1f654e0a | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Mast_cell-Mast_cell|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.67e-09 | 200 | 47 | 7 | a338b2b94901e4614ef78e82f580b67891f7c849 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.95e-09 | 143 | 47 | 6 | 091708a47ac55c6585923ee30190ff296fa87f6f | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-08 | 154 | 47 | 6 | 874b1220337276489a89fcc9a39bc81ba6b68baf | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-08 | 157 | 47 | 6 | 7ceae5fe00c91d4feb8c314d3a31f027c03fa56f | |
| ToppCell | 343B-Myeloid-Mast_cell-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-08 | 160 | 47 | 6 | a2f09b5955602819c8978f4372130c8ef915cd07 | |
| ToppCell | 343B-Myeloid-Mast_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-08 | 160 | 47 | 6 | 133ecae0a894d9a0d49d58859623359096b6f030 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass | 1.96e-08 | 163 | 47 | 6 | 7d7f18e5c99be125e95bc180823430291b770d05 | |
| ToppCell | Basal-basal-3|World / Class top | 2.99e-08 | 175 | 47 | 6 | a0d7ced5204a9efbbb91ac99410a088f8ed2df0f | |
| ToppCell | (4)_Mast_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.16e-08 | 185 | 47 | 6 | 3dd5d2237ab50b13a41c12f85e1b79cd72ea567b | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|World / Stress and Cell class | 4.16e-08 | 185 | 47 | 6 | b8cd94cf18308b514fc61557550225794ffd2860 | |
| ToppCell | (4)_Mast_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.16e-08 | 185 | 47 | 6 | c91e1081e630a61c18f6af6d198bfcf296746852 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-08 | 188 | 47 | 6 | 5e13725136114e42d3b59647cf25e0f3c53abb54 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-08 | 190 | 47 | 6 | 92456f6f7eced6e4c4371f495254a65d061c8d0b | |
| ToppCell | (0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 4.87e-08 | 190 | 47 | 6 | ff083168d609957d00888f31b3488d6d56c902b4 | |
| ToppCell | 390C-Myeloid-Mast_cell-|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.03e-08 | 191 | 47 | 6 | 88bcd0b85b2112cef15c9e44d1429f9fba4a3400 | |
| ToppCell | 390C-Myeloid-Mast_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.03e-08 | 191 | 47 | 6 | c1517ea7b10a7f732725b4c0224fbfecae80d18b | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.18e-08 | 192 | 47 | 6 | f40a7f8771aa9891a6fd59b9c8eac2fd792efa9b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-08 | 193 | 47 | 6 | ca7c0a4ceb05bced90f6cdc53d278e547fb241e9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.35e-08 | 193 | 47 | 6 | c17e87c042ef095ac99fdd6facf3bc2886924dc4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.51e-08 | 194 | 47 | 6 | dfe0ece81922bfd7c6673726d3ea2365cbdb5513 | |
| ToppCell | (0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 5.68e-08 | 195 | 47 | 6 | e8ab3122f81cb22920becd6611cbd9f00db19d50 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-08 | 195 | 47 | 6 | f41a68b7c2621594db8d8952e301eeadc96be26f | |
| ToppCell | 368C-Myeloid-Monocyte-CD14+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.68e-08 | 195 | 47 | 6 | 8da933942e9033e18e25ab47831c269747b1c0b2 | |
| ToppCell | 343B-Myeloid-Monocyte-CD14+_Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.68e-08 | 195 | 47 | 6 | b5ee368c97113432fc8fe742654cd538558f327c | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 5.86e-08 | 196 | 47 | 6 | d79a84aa25ba70483ae899cd5b52ba0bbffdcd7b | |
| ToppCell | normal_Lung-Myeloid_cells-mo-Mac|normal_Lung / Location, Cell class and cell subclass | 5.86e-08 | 196 | 47 | 6 | 4d3a3264b3d781139899448cde3b7a4f214ca14d | |
| ToppCell | kidney_cells-Adult_normal_reference|kidney_cells / Celltypes from Cells and Nuclei per compartment and clinical group | 5.86e-08 | 196 | 47 | 6 | 902965bfc5726ca0f1f0a1f6fe3f6d701cc91e6b | |
| ToppCell | 390C-Myeloid|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.86e-08 | 196 | 47 | 6 | 5b690062db162e9ddd1a32b1be4d10f5f99c9407 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.04e-08 | 197 | 47 | 6 | 0b2ad6a933ff1a325649cc8f139380fd158a1d42 | |
| ToppCell | BAL-Control-cDC_5|Control / Compartment, Disease Groups and Clusters | 6.04e-08 | 197 | 47 | 6 | 8a3fe59be3ed1f0254cc8c60b99c840193370efb | |
| ToppCell | Basal-basal-7|World / Class top | 6.22e-08 | 198 | 47 | 6 | 240fe56b41b9435e62c66ac7161ef51f89e73e44 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.22e-08 | 198 | 47 | 6 | a1c8e5c332336823c47c04e56b6d7bc8f057c9da | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.22e-08 | 198 | 47 | 6 | 294a48ef6c0b89c7be948452cea79d23d3901e75 | |
| ToppCell | mLN-B_cell-B_cell_memory|B_cell / Region, Cell class and subclass | 6.22e-08 | 198 | 47 | 6 | e2c63ca9f82f8524447e398b11a676b22d2f58ce | |
| ToppCell | (1)_T_cell-(12)_Th1|(1)_T_cell / shred on Cell_type and subtype | 6.41e-08 | 199 | 47 | 6 | 15133e0a4ea6cfcc27c1d438d9e854879ea84c30 | |
| ToppCell | Transverse|World / Region, Cell class and subclass | 6.60e-08 | 200 | 47 | 6 | 9dee983d7e43af8b3fbed795d8432af67b33c3b3 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.60e-08 | 200 | 47 | 6 | c30da72c3581d384b76c95f5989e32a36d783ef3 | |
| ToppCell | Transverse|World / shred on region, Cell_type, and subtype | 6.60e-08 | 200 | 47 | 6 | 1b4925a17be02f99b69c45f66577986a2dc107fd | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|lymph-node_spleen / Manually curated celltypes from each tissue | 5.11e-07 | 149 | 47 | 5 | 32b0a8789d3be4889821afab0b52214deeff7e4d | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.21e-07 | 155 | 47 | 5 | c4dc0fa1d0e657753a56939eb4829fb60382c17f | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.21e-07 | 155 | 47 | 5 | 84221a285277292f7225eb69508c887541abeed1 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.41e-07 | 156 | 47 | 5 | 5df19a235843829f5a1a90ca21b0964ef8b4e115 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.41e-07 | 156 | 47 | 5 | 029ba0832ee9c4a2c85620e4df2260e02d86b45c | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.83e-07 | 158 | 47 | 5 | de65af8d3b8514b17978155f31975e2347b75251 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.51e-07 | 169 | 47 | 5 | cd16e8462ee09877be962fbd9a3badcb825820b0 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|COVID-19 / Condition, Lineage and Cell class | 1.07e-06 | 173 | 47 | 5 | 502f888b7684ed39f5c577eedcacf673ae81d39e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-06 | 176 | 47 | 5 | a31d7532f8c055d4e62bbaa78d819f2495bfee00 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-06 | 179 | 47 | 5 | 2fca4117c58824562ec80c7713fe15689a28efb3 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-06 | 179 | 47 | 5 | 898425fa81526a2e00fca7a25085229ff1f31069 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.30e-06 | 180 | 47 | 5 | dcec59d66995f701d816eaeea3ed1439a2f71b73 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.30e-06 | 180 | 47 | 5 | f3d8329b7e754c1ed89b0f39b8cd9e2ae22f6725 | |
| ToppCell | Control-Myeloid-MoAM2|Control / Disease group,lineage and cell class （2021.01.30） | 1.30e-06 | 180 | 47 | 5 | 38892483a6a5388765aec87f0119c0b9bb5c7cbd | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Monocytes|normal_Lymph_Node / Location, Cell class and cell subclass | 1.45e-06 | 184 | 47 | 5 | 3cec28ff076fa53d034428de2bb1a237e0c1568c | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-06 | 187 | 47 | 5 | 6820bfbe552ea5e62cfe699687b051a17d9fda61 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-Trm_Th1/Th17|lymph-node_spleen / Manually curated celltypes from each tissue | 1.61e-06 | 188 | 47 | 5 | a20521198c6db17589535fb439533329582c9dd2 | |
| ToppCell | Mesenchymal_cells-Myofibroblasts|Mesenchymal_cells / Lineage and Cell class | 1.65e-06 | 189 | 47 | 5 | f5322429963257cfd3fd813d7b7d273d3d12d622 | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 1.65e-06 | 189 | 47 | 5 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.65e-06 | 189 | 47 | 5 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-06 | 192 | 47 | 5 | 71863f18a82394ed9f8e5ec8a4017215382a8284 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-06 | 192 | 47 | 5 | 60a02e0ccdc8c7af9bc875b248467304fe0d24a4 | |
| ToppCell | 367C-Myeloid-Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-06 | 192 | 47 | 5 | 26326d7c3d907d754e85e128b7d8a52e90863f3f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-06 | 192 | 47 | 5 | 5532ea1bc012eb9303197b87e90bc39619b5ee2a | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-06 | 192 | 47 | 5 | b223fca73e16668f69a78cf4457e349d01792540 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-06 | 192 | 47 | 5 | b5615a780b0ba24a8e554fac9238d3f0bcba52bc | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 1.83e-06 | 193 | 47 | 5 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | 367C-Myeloid-Monocyte-CD14+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-06 | 193 | 47 | 5 | c7ecd98729419b34c14f9b387b15472c47951d2f | |
| ToppCell | droplet-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 193 | 47 | 5 | cba070019db30604ebddb610eedf92e48221ac58 | |
| ToppCell | 10x5'-GI_small-bowel|World / Manually curated celltypes from each tissue | 1.83e-06 | 193 | 47 | 5 | cd89dfe53a114078f06343049685883c8e26508f | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 193 | 47 | 5 | 07ddb9525b686c31fa7df4286557d1e58f7ead52 | |
| ToppCell | 343B-Myeloid-Monocyte-CD14+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-06 | 193 | 47 | 5 | 24c06b0461894fe9f68bf26507d7a708468237c2 | |
| ToppCell | ILEUM-inflamed-(2)_B_cell-(2)_Memory_B_cells|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.83e-06 | 193 | 47 | 5 | a2ca508b1a6184579083f59419f4701c28d379ab | |
| ToppCell | Control-Myeloid-MoAM5,_CCL3L1|Control / Condition, Lineage and Cell class | 1.87e-06 | 194 | 47 | 5 | a1dd264822de83a0ffaf89ca4707c6a76809359e | |
| ToppCell | Bronchial_Brush-Immune-Dendritic_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.87e-06 | 194 | 47 | 5 | dbcc00940538efc0f89f074dbe822c50efa5ad8e | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia|World / Primary Cells by Cluster | 1.87e-06 | 194 | 47 | 5 | 1445b7611c2b1ab9b320f330d17d70117892cc28 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.05e-09 | 50 | 30 | 6 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_STRESS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.05e-09 | 50 | 30 | 6 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_STRESS_HSP | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.32e-07 | 50 | 30 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_5_STRESS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.32e-07 | 50 | 30 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_STRESS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.04e-05 | 50 | 30 | 4 | GAVISH_3CA_METAPROGRAM_B_CELLS_HSP_STRESS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.04e-05 | 50 | 30 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_HEAT_SHOCK | |
| Computational | Genes in the cancer module 87. | 2.41e-04 | 44 | 30 | 3 | MODULE_87 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.52e-04 | 50 | 30 | 3 | GAVISH_3CA_METAPROGRAM_B_CELLS_STRESS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.52e-04 | 50 | 30 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_STRESS | |
| Computational | Genes in the cancer module 123. | 5.48e-04 | 247 | 30 | 5 | MODULE_123 | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A | 9.87e-10 | 159 | 46 | 8 | 4328_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; PC3; HT_HG-U133A | 1.46e-09 | 167 | 46 | 8 | 6680_UP | |
| Drug | Dextroamphetamine | 3.27e-09 | 185 | 46 | 8 | ctd:D003913 | |
| Drug | Prenylamine lactate [69-43-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.29e-08 | 161 | 46 | 7 | 2886_UP | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; PC3; HT_HG-U133A | 4.79e-08 | 170 | 46 | 7 | 4680_UP | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.06e-07 | 191 | 46 | 7 | 2627_UP | |
| Drug | Antigen-Antibody Complex | 1.50e-07 | 24 | 46 | 4 | ctd:D000936 | |
| Drug | delta-tocopherol | 2.11e-07 | 26 | 46 | 4 | ctd:C479072 | |
| Drug | Lycorine hydrochloride [2188-68-3]; Up 200; 12.4uM; PC3; HT_HG-U133A | 6.26e-07 | 153 | 46 | 6 | 3808_UP | |
| Drug | N-((2,2-dimethyl-2,3-dihydrobenzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)benzylamine | 6.43e-07 | 9 | 46 | 3 | ctd:C518313 | |
| Drug | iododimethylarsine | 6.43e-07 | 9 | 46 | 3 | CID000069608 | |
| Drug | IBI-C83 | 6.43e-07 | 9 | 46 | 3 | CID000068764 | |
| Drug | Azacyclonol [115-46-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 6.51e-07 | 154 | 46 | 6 | 1520_UP | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 6.76e-07 | 155 | 46 | 6 | 1068_UP | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; HL60; HT_HG-U133A | 7.29e-07 | 157 | 46 | 6 | 1304_UP | |
| Drug | Suloctidil [54063-56-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 7.29e-07 | 157 | 46 | 6 | 2651_UP | |
| Drug | NSC305787 | 7.29e-07 | 35 | 46 | 4 | ctd:C570896 | |
| Drug | Azaguanine-8 [134-58-7]; Up 200; 26.2uM; PC3; HT_HG-U133A | 7.56e-07 | 158 | 46 | 6 | 1791_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; HL60; HT_HG-U133A | 7.85e-07 | 159 | 46 | 6 | 2192_UP | |
| Drug | Azaguanine-8 [134-58-7]; Up 200; 26.2uM; HL60; HT_HG-U133A | 7.85e-07 | 159 | 46 | 6 | 1833_UP | |
| Drug | gamma-Tocopherol | 8.19e-07 | 36 | 46 | 4 | ctd:D024504 | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A | 8.75e-07 | 162 | 46 | 6 | 3771_UP | |
| Drug | alpha-Tocopherol | 9.40e-07 | 164 | 46 | 6 | ctd:D024502 | |
| Drug | cadmium acetate | 9.40e-07 | 164 | 46 | 6 | ctd:C028031 | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | 9.74e-07 | 165 | 46 | 6 | 3770_UP | |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 1.01e-06 | 166 | 46 | 6 | 5324_UP | |
| Drug | felodipine; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 1.16e-06 | 170 | 46 | 6 | 965_UP | |
| Drug | Suloctidil [54063-56-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.16e-06 | 170 | 46 | 6 | 5021_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 1.20e-06 | 171 | 46 | 6 | 5026_UP | |
| Drug | Lynestrenol [52-76-6]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.67e-06 | 181 | 46 | 6 | 1537_UP | |
| Drug | Disulfiram [97-77-8]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.78e-06 | 183 | 46 | 6 | 2053_UP | |
| Drug | Fendiline hydrochloride [13636-18-5]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.78e-06 | 183 | 46 | 6 | 3190_UP | |
| Drug | Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.21e-06 | 190 | 46 | 6 | 5674_UP | |
| Drug | Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; PC3; HT_HG-U133A | 2.50e-06 | 194 | 46 | 6 | 4506_UP | |
| Drug | methyloxoarsine | 2.77e-06 | 14 | 46 | 3 | CID000092815 | |
| Drug | shikonin | 3.40e-06 | 51 | 46 | 4 | ctd:C016101 | |
| Drug | deoxynivalenol | 4.83e-06 | 481 | 46 | 8 | ctd:C007262 | |
| Drug | Haloperidol | 5.25e-06 | 342 | 46 | 7 | ctd:D006220 | |
| Drug | Water Pollutants | 5.33e-06 | 57 | 46 | 4 | ctd:D014873 | |
| Drug | AC1O5LBK | 8.89e-06 | 242 | 46 | 6 | CID006436256 | |
| Drug | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 9.02e-06 | 65 | 46 | 4 | ctd:D002259 | |
| Drug | 4-nitroquinoline | 1.00e-05 | 21 | 46 | 3 | CID000077341 | |
| Drug | SB 203580 | 1.19e-05 | 388 | 46 | 7 | ctd:C093642 | |
| Drug | Amphetamine | 1.20e-05 | 148 | 46 | 5 | ctd:D000661 | |
| Drug | Terfenadine [50679-08-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.36e-05 | 152 | 46 | 5 | 6823_UP | |
| Drug | Astemizole [68844-77-9]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.36e-05 | 152 | 46 | 5 | 6807_UP | |
| Drug | PCI 5002 | 1.37e-05 | 735 | 46 | 9 | ctd:C568608 | |
| Drug | Astemizole [68844-77-9]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 1.45e-05 | 154 | 46 | 5 | 2211_UP | |
| Drug | nickel chloride | ATF3 TFPT NR4A1 HSPA1A HSPA1B ATF2 HSPA8 FOSB FOSL2 BACH1 FOSL1 | 1.70e-05 | 1178 | 46 | 11 | ctd:C022838 |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.75e-05 | 160 | 46 | 5 | 4404_UP | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.75e-05 | 160 | 46 | 5 | 5275_UP | |
| Drug | Simvastatin | 1.90e-05 | 581 | 46 | 8 | ctd:D019821 | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 1.97e-05 | 164 | 46 | 5 | 3852_UP | |
| Drug | Proscillaridin A [466-06-8]; Up 200; 7.6uM; HL60; HT_HG-U133A | 1.97e-05 | 164 | 46 | 5 | 2920_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 1.97e-05 | 164 | 46 | 5 | 3963_UP | |
| Drug | Strophanthidin [66-28-4]; Up 200; 9.8uM; PC3; HT_HG-U133A | 2.09e-05 | 166 | 46 | 5 | 5826_UP | |
| Drug | Sanguinarine [2447-54-3]; Up 200; 12uM; HL60; HT_HG-U133A | 2.15e-05 | 167 | 46 | 5 | 2927_UP | |
| Drug | Acetylcysteine | 2.19e-05 | 780 | 46 | 9 | ctd:D000111 | |
| Drug | BW-B 70C; Up 200; 31.6uM; MCF7; HT_HG-U133A_EA | 2.28e-05 | 169 | 46 | 5 | 1132_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 2.34e-05 | 170 | 46 | 5 | 3945_UP | |
| Drug | Azetidinecarboxylic Acid | 2.39e-05 | 4 | 46 | 2 | ctd:D001383 | |
| Drug | calmidazolium chloride; Up 200; 5uM; MCF7; HT_HG-U133A_EA | 2.48e-05 | 172 | 46 | 5 | 906_UP | |
| Drug | 5255229; Up 200; 13uM; MCF7; HT_HG-U133A_EA | 2.55e-05 | 173 | 46 | 5 | 949_UP | |
| Drug | Felodipine [72509-76-3]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 2.69e-05 | 175 | 46 | 5 | 3295_UP | |
| Drug | Anisomycin | 2.74e-05 | 86 | 46 | 4 | ctd:D000841 | |
| Drug | Asbestos, Crocidolite | NR4A3 ATF3 NR4A1 HSPA1A HSPA1B ATF2 CREB5 FOSB FOSL2 BACH1 FOSL1 | 2.76e-05 | 1241 | 46 | 11 | ctd:D017638 |
| Drug | Fluspirilen [1841-19-6]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 2.84e-05 | 177 | 46 | 5 | 6463_UP | |
| Drug | 2-chloroethyl ethyl sulfide | 2.87e-05 | 87 | 46 | 4 | ctd:C031278 | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 3.08e-05 | 180 | 46 | 5 | 1477_UP | |
| Drug | Azacyclonol [115-46-8]; Up 200; 15uM; PC3; HG-U133A | 3.08e-05 | 180 | 46 | 5 | 1937_UP | |
| Drug | Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; HL60; HG-U133A | 3.25e-05 | 182 | 46 | 5 | 1755_UP | |
| Drug | Camptothecine (S,+) [7689-03-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 3.25e-05 | 182 | 46 | 5 | 2321_UP | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.33e-05 | 183 | 46 | 5 | 4732_UP | |
| Drug | Ozone | NR4A3 GNA12 ATF3 ADRA2C GNAS NR4A1 HSPA1A HSPA1B ATF2 HSPA8 FOSL1 | 3.48e-05 | 1273 | 46 | 11 | ctd:D010126 |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 3.60e-05 | 186 | 46 | 5 | 2684_UP | |
| Drug | Propofol [2078-54-8]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 3.70e-05 | 187 | 46 | 5 | 3386_UP | |
| Drug | celecoxib; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 3.89e-05 | 189 | 46 | 5 | 922_UP | |
| Drug | 2-phenylacetylenesulfonamide | 3.98e-05 | 5 | 46 | 2 | ctd:C545747 | |
| Drug | Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.99e-05 | 190 | 46 | 5 | 2629_UP | |
| Drug | Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; MCF7; HT_HG-U133A | 4.09e-05 | 191 | 46 | 5 | 5434_DN | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 4.09e-05 | 191 | 46 | 5 | 3392_UP | |
| Drug | Ethionamide [536-33-4]; Up 200; 24uM; PC3; HT_HG-U133A | 4.51e-05 | 195 | 46 | 5 | 4593_UP | |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; HL60; HG-U133A | 4.62e-05 | 196 | 46 | 5 | 1440_UP | |
| Drug | tetraethylenepentamine pentahydrochloride; Up 200; 100uM; ssMCF7; HG-U133A | 4.74e-05 | 197 | 46 | 5 | 498_UP | |
| Drug | AC1NDX9W | 4.83e-05 | 35 | 46 | 3 | CID004633087 | |
| Drug | Acrylamide | 4.97e-05 | 199 | 46 | 5 | ctd:D020106 | |
| Drug | Naphthalenes | 5.36e-05 | 102 | 46 | 4 | ctd:D009281 | |
| Drug | Plant Oils | 5.73e-05 | 496 | 46 | 7 | ctd:D010938 | |
| Drug | polaprezinc | 5.96e-05 | 6 | 46 | 2 | ctd:C061957 | |
| Drug | geranylgeranylacetone | 5.96e-05 | 6 | 46 | 2 | ctd:C031049 | |
| Drug | formetanate | 5.96e-05 | 6 | 46 | 2 | ctd:C100163 | |
| Drug | Benzene | 6.24e-05 | 892 | 46 | 9 | ctd:D001554 | |
| Drug | pyrrolidine dithiocarbamic acid | 6.86e-05 | 213 | 46 | 5 | ctd:C020972 | |
| Drug | hydroxyhydroquinone | 7.72e-05 | 112 | 46 | 4 | ctd:C013038 | |
| Drug | pirimicarb | 8.33e-05 | 7 | 46 | 2 | ctd:C011994 | |
| Drug | AC1MI4R0 | 8.33e-05 | 7 | 46 | 2 | CID003038396 | |
| Drug | Sertraline | 8.56e-05 | 115 | 46 | 4 | ctd:D020280 | |
| Drug | Chlorine | 9.15e-05 | 367 | 46 | 6 | ctd:D002713 | |
| Drug | Zinc Sulfate | 1.04e-04 | 739 | 46 | 8 | ctd:D019287 | |
| Drug | Methoxychlor | 1.08e-04 | 549 | 46 | 7 | ctd:D008731 | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 3.54e-08 | 5 | 46 | 3 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | event-related brain oscillation | 1.42e-05 | 4 | 46 | 2 | EFO_0004358 | |
| Disease | renal carcinoma (biomarker_via_orthology) | 2.37e-05 | 5 | 46 | 2 | DOID:4451 (biomarker_via_orthology) | |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 2.65e-05 | 37 | 46 | 3 | DOID:0050865 (is_marker_for) | |
| Disease | Major depression, single episode | 8.50e-05 | 9 | 46 | 2 | C0024517 | |
| Disease | Insulin Sensitivity | 1.14e-04 | 60 | 46 | 3 | C0920563 | |
| Disease | Insulin Resistance | 1.14e-04 | 60 | 46 | 3 | C0021655 | |
| Disease | Carcinoma, Pancreatic Ductal | 6.42e-04 | 24 | 46 | 2 | C0887833 | |
| Disease | colon adenocarcinoma (is_marker_for) | 6.97e-04 | 25 | 46 | 2 | DOID:234 (is_marker_for) | |
| Disease | complement C4b measurement | 6.97e-04 | 25 | 46 | 2 | EFO_0008092 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 1.13e-03 | 131 | 46 | 3 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 1.13e-03 | 131 | 46 | 3 | C4552091 | |
| Disease | Juvenile arthritis | 1.13e-03 | 131 | 46 | 3 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 1.13e-03 | 131 | 46 | 3 | C3714758 | |
| Disease | Juvenile-Onset Still Disease | 1.23e-03 | 135 | 46 | 3 | C0087031 | |
| Disease | systemic lupus erythematosus | 1.44e-03 | 799 | 46 | 6 | MONDO_0007915 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IRRRSKNRIAAQRCR | 561 | O14867 | |
| RREVQDAFRCRLRNC | 1151 | O60242 | |
| SVCRRKVAQAREKRF | 366 | P18825 | |
| EDRRRAAAQQCRSRR | 26 | Q96NS5 | |
| DQAARKIMRFLRRCR | 1166 | O94983 | |
| RKFLERNRAAASRCR | 356 | P15336 | |
| RNRAAASRCRQKRKV | 361 | P15336 | |
| QRFLERNRAAASRCR | 336 | P17544 | |
| RNRAAASRCRQKRKL | 341 | P17544 | |
| RFREARRQFCRMRGS | 56 | Q8N1D0 | |
| QNYSALRRDCRRRKV | 11 | O15484 | |
| RRRQFTDVNRFTLRC | 306 | Q5VVQ6 | |
| VDKRRRNRCQFCRFQ | 311 | P22736 | |
| RVLRARCRRAVKSNA | 516 | O60840 | |
| FLERNRAAATRCRQK | 381 | Q02930 | |
| RRRDRINRCLNELGK | 21 | A6NFD8 | |
| VHTRRRCRNRFVKKN | 36 | Q14500 | |
| SANKCAFRVRRKSRR | 1126 | Q9ULI0 | |
| ERCLEEQKRRRQRAT | 226 | Q8NDV2 | |
| NKRAVRRLRTACERA | 256 | P0DMV9 | |
| QRRRKVRKASRSFQC | 361 | Q9H3R0 | |
| CRRARIRDRKAQQVF | 421 | Q96FE5 | |
| AELCRQKRVFNARNR | 26 | Q9H4K1 | |
| RRERNKLAAAKCRNR | 161 | P53539 | |
| KCRNRRRELTDRLQA | 171 | P53539 | |
| FAVSDCRRRFQERLR | 501 | Q86VX9 | |
| CRRRFQERLRKRGAH | 506 | Q86VX9 | |
| RERNKLAAAKCRNRR | 131 | P15408 | |
| DVQRYLVQCFDRKRR | 326 | Q03113 | |
| NIRRVFNDCRDIIQR | 371 | P63092 | |
| RRRERNKIAAAKCRN | 91 | P18847 | |
| KRNERERQRVRCVNE | 76 | Q6XD76 | |
| LRRVAVDKCARRVRQ | 166 | Q9P2N6 | |
| RRAKLQQCRAERERI | 141 | Q9NQR7 | |
| NKRAVRRLRTACERA | 256 | P0DMV8 | |
| RRERNKLAAAKCRNR | 111 | P15407 | |
| NKRAVRRLRTACERA | 256 | P11142 | |
| VDKRRRNRCQYCRFQ | 336 | Q92570 | |
| VHTRRRCRNRFVKKN | 36 | B7U540 | |
| FKNKRARCRRHQREL | 151 | Q8NHV9 | |
| KFIRLCGNRRRARAV | 361 | Q6NUJ1 | |
| RIFAFICRKHRIQRV | 486 | Q8WV83 | |
| QRARRSNCRRQEGIK | 86 | E9PKD4 | |
| RRNRRRLFSINECKI | 176 | Q15669 | |
| RLKRELEQARQARVC | 636 | P12755 | |
| RLADVFNQRCEVNRR | 206 | Q92989 | |
| GFQTEQIRKRLRCRR | 266 | Q8TCW9 | |
| GQNCLEVRTRRRRKD | 451 | O15156 | |
| ELNRRKYQALGRRCR | 76 | P0C1Z6 | |
| FRENGRNCKRERDAR | 271 | O95947 | |
| RLARQRIIQFQARCR | 811 | Q13402 |